Pre-market volume spike: OneApex (5SY.SI, SES) 19.67x volume, S$0.44 open, watch breakout
Pre-market volume spike on 5SY.SI stock as OneApex opens S$0.44; quick analysis, grade and S$0.40 target
-
-
SJR-B.TO C$40.48 Shaw Communications (TSX) intraday most active 05 Mar 2026: volume spike
Intraday update on SJR-B.TO stock: Shaw Communications (TSX) at C$40.48 on 05 Mar 2026 with heavy volume and elevated liquidity
-
DNK.AX Danakali ASX A$0.41 pre-market most active 06 Mar 2026: trading signals
Pre-market note on DNK.AX stock at A$0.41 with Meyka AI grade and A$0.33 forecast
-
KOSPI Index Today, March 6: Near 10% Rebound After Record Plunge, Oil Up
KOSPI index jumps nearly 10% after a record fall, while oil climbs on Middle East risks and Qatar LNG shock. Implications and tactics for Singapore investors today.
-
CASBF CanSino Biologics Inc. (PNK) up to $3.97 on 05 Mar 2026: watch analyst targets
CASBF stock jumps to $3.97 on 05 Mar 2026 during market hours; top-gainer analysis, Meyka AI forecast and risks
-
SUPERSHAKT.BO down 14.80% to INR 213 on BSE 05 Mar 2026: support near INR 212
SUPERSHAKT.BO stock falls 14.80% to INR 213 on BSE; quick fundamentals, technicals and Meyka AI forecast included
-
^GSPC Today March 6: NYT on Trump’s Iran Moves Stoke Risk-Off Bid
S&P 500 today edges higher as New York Times Trump Iran reporting and Iran escalation risks raise uncertainty. Key levels, technicals, and Singapore-focused positioning with data-driven takeaways.
-
Galderma (GALD.SW, SIX) up 7.93% after-hours 05 Mar 2026: earnings drive next moves
After-hours GALD.SW stock earnings recap: price CHF155.20, +7.93%, Meyka AI forecast and grade
-
2496.HK YZY Biopharma (HKSE) down 20.28% pre-market 06 Mar 2026: key insight
2496.HK stock down 20.28% to HKD 5.70 pre-market 06 Mar 2026; outlook, Meyka grade and forecast included
-
Imanishi Case March 06: Supreme Court Acquittal Spurs Retrial Law Debate
Japan’s March 3 Supreme Court acquittal in the Imanishi case spotlights disputed AHT evidence and fuels retrial law reform debate. What it means for legal risk, insurers, and hospitals in Japan.
